Psychedelics

Bipartisan lawmakers in Congress introduced several drug policy reform amendments in a large-scale advocacy bill to the National Defense Authorization Act (NDAA), reported Marijuana Moment. Banning federal employment discrimination against veterans who use marijuana, providing funding for studies...

Biotech psychedelics company BetterLife Pharma Inc. (OTCQB: BETRF) in collaboration with the Carleton University Dept. of Neuroscience has received funding from the Mitacs Accelerate Program for research into the antidepressant effects and action mechanism of BETR-001 in preclinical...

In a document published in the Federal Register, the Drug Enforcement Administration (DEA) announced it will hold a hearing on August 22, 2022, on its controversial proposal to place five psychedelic compounds in Schedule I.  The first plan to schedule the five tryptamines - 4-OH-DiPT, 5-...

Psychedelic drug discovery & optimization company CaaMTech Inc. and the psychedelics discovery, development & educational organization Alexander Shulgin Research Institute Inc. (ASRI) have recently signed an agreement to carry out structural and chemical analyses to further develop novel...

After the successful 4/20 event in Miami, the Benzinga Cannabis Capital Conference is coming to Chicago on September 13-14 with leading executives, investors and entrepreneurs of the industry. The Chicago list of speakers includes lawyer Carlos "Los" Arias, founder and...

“Language Models Learn Sentiment and Substance from 11,000 Psychoactive Experiences,” is a research project that took nearly 12,000 drug reports with 52 different molecules and combined them with 3 robotics models to characterize all the trajectories of meaning and feeling as...

Canadian premium magic mushroom producer Red Light Holland Corp. (OTC Pink: TRUFF) will dissolve its Oregon-based partnership with Canadian cannabis company Halo Collective (OTCQB: HCANF), reported Willamette Week.   The reason? Red Light intends to pursue a new program in the same...

Biotech therapeutics company Awakn Life Sciences Corp. (OTCQB: AWKNF) will receive funding from national agency Innovate UK destined to identifying the quickest and most cost-effective route to market in the UK and the US for Awakn's lead program: proprietary ketamine-assisted therapy for...

Marijuana Strategic Ventures, Inc. (OTCPK:MSVI) has officially changed its name to Mushrooms, Inc., through the filing of amended and restated articles of incorporation with the Nevada Secretary of State. In addition to changing the company’s corporate name to Mushrooms, Inc., the company...

This article was originally published on Psychedelic Spotlight and appears here with permission.   Microdosing psychedelics is more popular than ever, but is there any evidence that it works? We unpack the great microdosing debate. The psychedelic field goes through many trends, but the...

In a recent article in Psychology Today, Danilo Bzdok, M.D. goes through the novel research using natural-language processing tools in machine learning to understand conscious awareness and how drugs alter it. Although understanding the brain would seem like an eternal task, some of the...

Cartography of the Mind has raised over $1.5 million. Proceeds of this single-largest philanthropic art sale presented by Christie’s in collaboration with Ryan Zurrer (Dialectic and Vine Ventures) will benefit MAPS’ psychedelics research. The exhibition of the digital art...

Rep. Matt Gaetz (R-Fla) recently filed an amendment to explore the therapeutic potential of magic mushrooms and MDMA for military service members through research that would be included in the annual defense bill as an attachment to the National Defense Authorization Act (...

Psychedelic therapies developer and provider Field Trip Health Ltd. (TSX: FTRP) (NASDAQ: FTRP) reported fiscal fourth quarter and full year 2022 results for the period ended March 31, 2022 and completed a strategic review resulting in the intention to separate the Field Trip Discovery and Field...

As reported by Marijuana Moment, officials of the U.S. National Institutes of Health (NIH) replied to two senators’ request for a psychedelics research update with a letter stating that federal prohibition makes it harder to study the benefits of psychedelics.   “Because...